Array BioPharma (ARRY) Reports Q1 Loss of $0.52, Beats by 3c
More News related to ARRY
- Array BioPharma to Present at the Piper Jaffray Healthcare Conference
- UBS Upgrades Array BioPharma (ARRY) to Buy
- Array BioPharma (ARRY) Reports Q1 Loss of $0.52, Beats by 3c
- Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
- Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2010 on November 2, 2009
Array BioPharma Inc. (NASDAQ: ARRY) reports Q1 loss of $0.52, 3 cents better than the analyst estimate of ($0.55). Revenue for the quarter was $7.9 million, which compares to the estimate of $7.52 million.
Related Categories
EarningsStocks Mentioned
-0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
